Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CN Energy Group A | CNEY | Nov 25, 2024 | 0.34 | +3.06 |
CNA Financial | CNA | Nov 25, 2024 | 49.72 | +0.24 |
CNB Financial | CCNE | Nov 25, 2024 | 28.38 | +0.89 |
CNB Financial Pref | CCNEP | Nov 25, 2024 | 24.95 | -0.30 |
CNFinance ADR | CNF | Nov 25, 2024 | 0.99 | +3.00 |
CNH Industrial N.V. | CNH | Nov 25, 2024 | 12.65 | +4.12 |
CNO Financial Group | CNO | Nov 25, 2024 | 40.33 | +1.05 |
CNS Pharmaceuticals | CNSP | Nov 25, 2024 | 0.12 | -7.56 |
CNX Resources | CNX | Nov 25, 2024 | 40.41 | -1.65 |
Co-Diagnostics | CODX | Nov 25, 2024 | 0.99 | -1.98 |
Coastal Financial | CCB | Nov 25, 2024 | 77.98 | +1.69 |
Coca-Cola | KO | Nov 25, 2024 | 64.38 | +0.72 |
Coca-Cola Consolidated | COKE | Nov 25, 2024 | 1 299.60 | +3.15 |
Coca-Cola Europacific Partners | CCEP | Nov 25, 2024 | 78.14 | -0.09 |
Coca-Cola FEMSA ADR | KOF | Nov 25, 2024 | 80.06 | +1.26 |
Cocrystal Pharma | COCP | Nov 25, 2024 | 2.17 | -1.36 |
Coda Octopus | CODA | Nov 25, 2024 | 9.38 | +0.64 |
Codere Online Luxembourg | CDRO | Nov 25, 2024 | 7.72 | +1.58 |
Codexis | CDXS | Nov 25, 2024 | 4.55 | -1.30 |
Coeptis Therapeutics | COEP | Nov 25, 2024 | 0.20 | +1.49 |
Coeur Mining | CDE | Nov 25, 2024 | 6.30 | -4.11 |
Coffee Holding Company | JVA | Nov 25, 2024 | 3.48 | -0.29 |
Cogent Biosciences | COGT | Nov 25, 2024 | 9.19 | +0.66 |
Cogent Communications | CCOI | Nov 25, 2024 | 83.02 | -0.16 |
Cognex | CGNX | Nov 25, 2024 | 41.53 | +2.11 |
Cognition Therapeutics | CGTX | Nov 25, 2024 | 0.41 | -4.84 |
Cognizant Technology Solutions A | CTSH | Nov 25, 2024 | 80.63 | +1.37 |
Cognyte Software | CGNT | Nov 25, 2024 | 7.95 | +1.66 |
Cohen & Company | COHN | Nov 25, 2024 | 9.89 | -3.04 |
Cohen & Steers | CNS | Nov 25, 2024 | 105.55 | +2.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.